97507494 - KERNAL BIOLOGICS

Information

  • Trademark
  • 97507494
  • Serial Number
    97507494
  • Filing Date
    July 18, 2022
    2 years ago
  • Transaction Date
    September 05, 2024
    22 days ago
  • Status Date
    September 03, 2024
    24 days ago
  • Published for Opposition Date
    September 03, 2024
    24 days ago
  • Location Date
    August 01, 2024
    a month ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    VENGURLEKAR, SAGAR
  • Attorney Docket Number
    61600-TM1001
    Attorney Name
    Brandon P. Leahy
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
4
Mark Identification
KERNAL BIOLOGICS
Case File Statements
  • GS0051: Medical, biological, and pharmaceutical preparations for treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; medical, biological and pharmaceutical preparations containing lipid nanoparticles for the prevention and treatment of cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; RNA-based therapeutics and therapeutic agents for in vitro preparation and in vivo, ex vivo, or on vivo delivery to cell sites; nucleic acid sequences and chemical reagents for medical and veterinary purposes
  • GS0011: Chemicals for use in biotechnological manufacturing processes; Chemicals for use in biotechnological product development; Biochemicals for use in biotechnological manufacturing processes and product development, namely, protein-encoding nucleic acids and polypeptide-encoding nucleic acids related to treating cancers, auto-immune diseases, cardio metabolic diseases, infectious diseases, inflammatory diseases, and metabolic diseases; nucleotides for scientific and research use; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; protein arrays and nucleotide arrays for scientific and medical research; nucleic acid for laboratory use; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; nucleic acid sequences for scientific purposes; polypeptide encoding nucleic acids for laboratory use
  • DS0000: "BIOLOGICS"
Case File Event Statements
  • 7/21/2022 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/8/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/3/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 5/3/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/3/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/3/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/21/2023 - a year ago
    7 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 7/21/2023 - a year ago
    8 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 10/18/2023 - 11 months ago
    9 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/18/2023 - 11 months ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/18/2023 - 11 months ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/18/2023 - 11 months ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/18/2023 - 11 months ago
    13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/30/2023 - 11 months ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/30/2023 - 11 months ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/30/2023 - 11 months ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/4/2023 - 9 months ago
    17 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/4/2023 - 9 months ago
    18 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/4/2023 - 9 months ago
    19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/1/2024 - a month ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/1/2024 - a month ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/1/2024 - a month ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 8/1/2024 - a month ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 8/1/2024 - a month ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/3/2024 - 24 days ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/3/2024 - 24 days ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/14/2024 - a month ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP